[Endothelin receptor antagonists in the new European guidelines on pulmonary hypertension]
- PMID: 20206056
- DOI: 10.1016/j.rmr.2009.12.007
[Endothelin receptor antagonists in the new European guidelines on pulmonary hypertension]
Comment on
-
[Endothelin receptor antagonists - their role in pulmonary medicine].Rev Mal Respir. 2009 Dec;26(10):1075-90. doi: 10.1016/s0761-8425(09)73534-x. Rev Mal Respir. 2009. PMID: 20032843 Review. French.
-
[Guidelines for the diagnosis and treatment of pulmonary hypertension].Rev Mal Respir. 2010 Feb;27(2):141-50. doi: 10.1016/j.rmr.2009.11.013. Epub 2010 Feb 12. Rev Mal Respir. 2010. PMID: 20206062 Review. French.
Similar articles
-
[Specific drugs for the treatment of pulmonary arterial hypertension - current status].Dtsch Med Wochenschr. 2008 Oct;133 Suppl 6:S183-6. doi: 10.1055/s-0028-1091234. Epub 2008 Sep 23. Dtsch Med Wochenschr. 2008. PMID: 18814092 Review. German.
-
Ironic case of hepatic dysfunction following the global withdrawal of sitaxentan.Intern Med J. 2012 Dec;42(12):1351-4. doi: 10.1111/imj.12007. Intern Med J. 2012. PMID: 23253000
-
Endothelin receptor antagonists for pulmonary hypertension in adult patients with sickle cell disease.Br J Haematol. 2009 Dec;147(5):737-43. doi: 10.1111/j.1365-2141.2009.07906.x. Epub 2009 Sep 22. Br J Haematol. 2009. PMID: 19775299 Free PMC article.
-
Oral Therapies for the treatment of pulmonary arterial hypertension: a population-based cost-minimization analysis.Appl Health Econ Health Policy. 2010;8(1):69-71; author reply 71-3. doi: 10.1007/BF03256167. Appl Health Econ Health Policy. 2010. PMID: 20238466 No abstract available.
-
[Guidelines for the diagnosis and treatment of pulmonary hypertension].Rev Mal Respir. 2010 Feb;27(2):141-50. doi: 10.1016/j.rmr.2009.11.013. Epub 2010 Feb 12. Rev Mal Respir. 2010. PMID: 20206062 Review. French.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical